Rinta Ibuki

1.1k total citations
25 papers, 960 citations indexed

About

Rinta Ibuki is a scholar working on Pharmaceutical Science, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Rinta Ibuki has authored 25 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmaceutical Science, 7 papers in Pediatrics, Perinatology and Child Health and 5 papers in Oncology. Recurrent topics in Rinta Ibuki's work include Drug Solubulity and Delivery Systems (7 papers), Advanced Drug Delivery Systems (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). Rinta Ibuki is often cited by papers focused on Drug Solubulity and Delivery Systems (7 papers), Advanced Drug Delivery Systems (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). Rinta Ibuki collaborates with scholars based in Japan, United States and China. Rinta Ibuki's co-authors include Atsuo Ohike, Kazuto Okimoto, Yuji Tokunaga, Kazutaka Higaki, Toshikiro Kimura, Toshiomi Nakate, Kazunari Yamashita, Shigeki Tamura, Gordon L. Amidon and Shinji Yamashita and has published in prestigious journals such as Journal of Controlled Release, Journal of Pharmacology and Experimental Therapeutics and International Journal of Pharmaceutics.

In The Last Decade

Rinta Ibuki

24 papers receiving 872 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rinta Ibuki Japan 14 713 244 144 99 99 25 960
Sailesh A. Varia United States 18 480 0.7× 196 0.8× 155 1.1× 79 0.8× 113 1.1× 32 1.0k
Martin H. Infeld United States 16 851 1.2× 153 0.6× 203 1.4× 59 0.6× 117 1.2× 29 1.1k
Atsuo Ohike Japan 10 467 0.7× 163 0.7× 97 0.7× 67 0.7× 66 0.7× 16 674
Karl Kolter Germany 19 883 1.2× 300 1.2× 204 1.4× 46 0.5× 152 1.5× 40 1.3k
Delphine Marchaud France 11 815 1.1× 177 0.7× 103 0.7× 115 1.2× 153 1.5× 16 1.0k
Waseem Malick United States 13 735 1.0× 252 1.0× 151 1.0× 35 0.4× 115 1.2× 16 998
Kazuto Okimoto Japan 13 815 1.1× 297 1.2× 201 1.4× 32 0.3× 179 1.8× 19 1.0k
Ahmed Abd El-Bary Egypt 24 626 0.9× 165 0.7× 113 0.8× 65 0.7× 77 0.8× 54 1.2k
Yoshie Masaoka Japan 19 701 1.0× 223 0.9× 114 0.8× 300 3.0× 116 1.2× 35 1.1k
Tamer Baykara Türkiye 17 740 1.0× 137 0.6× 94 0.7× 52 0.5× 67 0.7× 38 1.2k

Countries citing papers authored by Rinta Ibuki

Since Specialization
Citations

This map shows the geographic impact of Rinta Ibuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rinta Ibuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rinta Ibuki more than expected).

Fields of papers citing papers by Rinta Ibuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rinta Ibuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rinta Ibuki. The network helps show where Rinta Ibuki may publish in the future.

Co-authorship network of co-authors of Rinta Ibuki

This figure shows the co-authorship network connecting the top 25 collaborators of Rinta Ibuki. A scholar is included among the top collaborators of Rinta Ibuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rinta Ibuki. Rinta Ibuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aoshima, Hisae, et al.. (2024). Inhibitory Effect of 2-Aza-8-oxohypoxanthine on Tyrosinase Activity and Melanin Production. Cosmetics. 11(2). 43–43.
2.
Aoshima, Hisae, Shinobu Ito, Rinta Ibuki, & Hirokazu Kawagishi. (2022). Potential of Fairy Chemicals as Functional Cosmetic Ingredients: Effect of 2-Aza-8-Oxohypoxanthine on Skin Lightness. International journal of medicinal mushrooms. 24(9). 41–47. 4 indexed citations
3.
Aoshima, Hisae, et al.. (2021). The Potential of 2-aza-8-Oxohypoxanthine as a Cosmetic Ingredient. Cosmetics. 8(3). 60–60. 6 indexed citations
4.
Aoshima, Hisae, et al.. (2021). Safety evaluation of 2-aza-8-oxohypoxanthine by <i>in vitro</i> skin sensitization and human tests. Fundamental Toxicological Sciences. 8(4). 123–133. 6 indexed citations
5.
Tanaka, Nobuyuki, Keiji Imai, Kazuto Okimoto, et al.. (2006). Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): In vivo evaluation. Journal of Controlled Release. 112(1). 51–56. 76 indexed citations
6.
Tanaka, Nobuyuki, Keiji Imai, Kazuto Okimoto, et al.. (2005). Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine. Journal of Controlled Release. 108(2-3). 386–395. 59 indexed citations
7.
Tamura, Shigeki, Atsuo Ohike, Yuji Tokunaga, et al.. (2004). Effect of Experimental Acute Renal and Hepatic Failure on Absorption of Tacrolimus in Rat Small Intestine. Drug Metabolism and Pharmacokinetics. 19(3). 190–197. 4 indexed citations
8.
Okimoto, Kazuto, Yuji Tokunaga, Rinta Ibuki, et al.. (2004). Applicability of (SBE)7m-β-CD in controlled-porosity osmotic pump tablets (OPTs). International Journal of Pharmaceutics. 286(1-2). 81–88. 43 indexed citations
9.
Nakate, Toshiomi, H. Yoshida, Atsuo Ohike, et al.. (2004). Formulation development of inhalation powders for FK888 with carrier lactose using Spinhaler® and its absorption in healthy volunteers. Journal of Controlled Release. 97(1). 19–29. 16 indexed citations
10.
Nakate, Toshiomi, H. Yoshida, Atsuo Ohike, et al.. (2004). Formulation development of inhalation powders for FK888 using the E-haler® to improve the inhalation performance at a high dose, and its absorption in healthy volunteers. European Journal of Pharmaceutics and Biopharmaceutics. 59(1). 25–33. 13 indexed citations
11.
Yamashita, Kazunari, Toshiomi Nakate, Kazuto Okimoto, et al.. (2003). Establishment of new preparation method for solid dispersion formulation of tacrolimus. International Journal of Pharmaceutics. 267(1-2). 79–91. 295 indexed citations
12.
Nakate, Toshiomi, H. Yoshida, Atsuo Ohike, et al.. (2003). Comparison of the lung absorption of FK224 inhaled from a pressurized metered dose inhaler and a dry powder inhaler by healthy volunteers. European Journal of Pharmaceutics and Biopharmaceutics. 56(3). 319–325. 7 indexed citations
13.
Tamura, Shigeki, Yuji Tokunaga, Rinta Ibuki, et al.. (2003). The Site-Specific Transport and Metabolism of Tacrolimus in Rat Small Intestine. Journal of Pharmacology and Experimental Therapeutics. 306(1). 310–316. 50 indexed citations
14.
Tamura, Shigeki, et al.. (2003). In vitro release of Tacrolimus from Tacrolimus ointment and its speculated mechanism. International Journal of Pharmaceutics. 270(1-2). 55–64. 14 indexed citations
15.
Tamura, Shigeki, Atsuo Ohike, Rinta Ibuki, Gordon L. Amidon, & Shinji Yamashita. (2002). Tacrolimus is a class II low-solubility high-permeability drug: The effect of P-glycoprotein efflux on regional permeability of tacrolimus in rats. Journal of Pharmaceutical Sciences. 91(3). 719–729. 121 indexed citations
16.
Okimoto, Kazuto, Atsuo Ohike, Rinta Ibuki, et al.. (1999). Design and Evaluation of an Osmotic Pump Tablet (OPT) for Chlorpromazine Using (SBE)7m-β-CD. Pharmaceutical Research. 16(4). 549–554. 36 indexed citations
17.
Okimoto, Kazuto, Atsuo Ohike, Rinta Ibuki, et al.. (1999). Factors affecting membrane-controlled drug release for an osmotic pump tablet (OPT) utilizing (SBE)7m-β-CD as both a solubilizer and osmotic agent. Journal of Controlled Release. 60(2-3). 311–319. 38 indexed citations
18.
Ohike, Atsuo, et al.. (1999). Granulation Monitoring by Fast Fourier Transform Technique.. Chemical and Pharmaceutical Bulletin. 47(12). 1734–1739. 16 indexed citations
19.
Okimoto, Kazuto, et al.. (1997). Dissolution mechanism and rate of solid dispersion particles of nilvadipine with hydroxypropylmethylcellulose. International Journal of Pharmaceutics. 159(1). 85–93. 78 indexed citations
20.
Ueda, Satoshi, et al.. (1994). Development of a Novel Drug Delivery System, Time-Controlled Explosion System (TES). IV.In VivoDrug Release Behavior. Journal of drug targeting. 2(2). 133–140. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sailesh A. Varia Breakdown of academic impact, for papers by Martin H. Infeld Breakdown of academic impact, for papers by Atsuo Ohike Breakdown of academic impact, for papers by Karl Kolter Breakdown of academic impact, for papers by Delphine Marchaud Breakdown of academic impact, for papers by Waseem Malick Breakdown of academic impact, for papers by Kazuto Okimoto Breakdown of academic impact, for papers by Ahmed Abd El-Bary Breakdown of academic impact, for papers by Yoshie Masaoka Breakdown of academic impact, for papers by Tamer Baykara
Rankless by CCL
2026